STREAMEX CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
STREAMEX CORP. (STEX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $1.03 per share for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2023-08-14
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2020-03-31 was $3.73, a 12.11% decline year-over-year.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2019-03-31 was $4.24.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2019 was $5.75, a 70.62% increase from fiscal 2018.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2018 was $3.37, a 15.21% increase from fiscal 2017.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2017 was $2.92, a 98.98% increase from fiscal 2016.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2016 was $1.47.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|
| 2023-06-30 | $1.03 10-Q · filed 2023-08-14 | ||||
| 2020-09-30 | $4.02 10-Q · filed 2020-11-05 | ||||
| 2020-06-30 | $3.98 10-Q · filed 2020-08-06 | ||||
| 2020-03-31 | $3.73 10-Q · filed 2020-05-11 | ||||
| 2019-12-31 | $5.75 10-K · filed 2020-03-13 | ||||
| 2019-03-31 | $4.24 10-Q · filed 2019-04-15 | ||||
| 2018-12-31 | $3.37 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | $3.20 10-Q · filed 2018-11-02 | ||||
| 2018-06-30 | $1.28 10-Q · filed 2018-07-27 | ||||
| 2017-12-31 | $2.92 10-K · filed 2019-03-15 | $1.17 10-K · filed 2018-02-27 | |||
| 2016-12-31 | $1.47 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $1.50 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | $1.58 10-Q · filed 2016-08-12 | ||||
| 2015-09-30 | $2.41 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | $2.14 10-Q · filed 2016-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |